Name: TRVI Balance Sheet - Trevi Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

TRVI - Trevi Therapeutics, Inc.

USD | NASDAQ | Healthcare

TRVI Balance Sheet - Trevi Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17
Cash And Short Term Investments
Cash And Equivalents	19.4	18.9	56.9	117.1	19.4	34.1	16.1	13.0	13.8	32.4	26.0	13.8	11.7	12.6	66.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash And Short Term Investments
Cash And Equivalents	18.9	34.1	32.4	12.6	36.8	45.0	57.3	7.2	-
Restricted Cash	-	-	-	-	-	-	-	-	-
Short Term Investments	169.3	73.5	50.6	107.9	-	-	-	-	-
Cash And Short Term Investments	188.3	107.6	83.0	120.5	36.8	45.0	57.3	7.2	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-
Prepaid Expenses	1.3	0.9	3.6	0.8	0.9
Non-Current Assets
Property, Plant & Equipment Gross	0.5	0.4	0.4	0.4	0.2	0.2	0.2	0.2	-
Accumulated Depreciation	0.4	0.2	0.1
Current Liabilities
Accounts Payable	3.9	3.4	1.8	2.9	2.8	2.0	1.6	0.6	-
Short Term Debt	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.4	0.7	1.0	0.0
Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	512.8	386.5	321.6	317.6	198.0
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-
Additional Paid In Capital	515.2	512.8	511.1	508.0	396.7	386.5	334.4	328.6	322.4	321.6	321.1	318.9	318.2	317.6	314.7	256.9	198.7
Retained Earnings	(343.0)	(329.8)	(321.5)	(309.7)	(297.4)	(287.0)	(275.6)	(262.4)	(250.0)	(239.1)	(231.3)	(223.6)	(216.5)	(210.1)	(204.6)	(196.3)	(188.2)
Accumulated Other Comprehensive Income	(0.2)	0.1	0.0	0.0	0.1	0.1	0.1	(0.1)	(0.1)	(0.0)	(0.2)	(0.2)	(0.1)	(0.1)	(0.3)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	172.1	183.2	189.8	198.5	99.5	99.6	59.0	66.2	72.3	82.5	89.6	95.1	101.7	107.5	109.9	60.5	10.5
Total Equity	172.1	183.2	189.8	198.5	99.5	99.6	59.0	66.2	72.3	82.5	89.6	95.1	101.7	107.5	109.9	60.5	10.5	17.1

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	169.0	181.9	189.3	198.0	98.8	98.9	58.2	65.4	71.5	81.7	88.8	94.5	101.0	109.2	112.7	64.5	17.0	25.2
Book Value	172.1	183.2	189.8	198.5	99.5	99.6	59.0	66.2	72.3	82.5	89.6	95.1	101.7	107.5	109.9	60.5	10.5	17.1
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Current Liabilities
Accounts Payable	2.2	3.9	2.7	3.0	1.4	3.4	1.6	1.5	2.1	1.8	1.3	1.4	2.0	2.9	2.3	3.9	1.7	2.8	2.2	3.5	0.8	2.0	1.3	3.2	2.2	1.6	0.5	2.7	0.5	0.6	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.1	0.1
Accrued Expenses	4.6	5.5	6.0	6.0	5.2	6.8	7.2	4.9	2.8	3.7	3.6	3.1	3.5	3.5	5.2	4.4	3.9	3.8
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	7.1	9.7	9.0	9.2	6.9	10.5	9.1	6.8	5.3	5.8	5.2	4.7	13.2	13.4	14.6	15.4